Clinical Trial

Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2027-09 2026-06-12
minor Completion pushed: 2026-09 -> 2027-09 2026-06-12
Trial Details
NCT Number NCT07034261
Lead Sponsor University of Chicago
Conditions Gestational Diabetes
Enrollment 50 participants
Start Date 2026-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-11